Andrew Scholey Professor of Human Psychopharmacology based in Melbourne, Australia. He has researched a number of areas
of psychopharmacology, including the brain and behavioural effects of
'nutra' interventions (nutrition, nutrients, nutraceuticals), caffeine,
drugs and alcohol. He is a leading authority on the neurocognitive
effects of nutrition, natural products, supplements and food
In 1998, Andrew established the Human
Cognitive Neuroscience Unit at Northumbria University, UK (now the
Brain Performance and Nutrition Research Centre) and was the Unit’s
director until joining Swinburne
in 2007. He was also co-director of the UK’s Medicinal
Plant Research Centre and remains as honorary director of
Andrew has been lead investigator in a series of landmark studies
into the human biobehavioural effects of natural products, and their
neurocognition-enhancing and anti-stress/anxiolytic properties. These
include first-into-human, placebo-controlled trials evaluating Panax
ginseng, Panax quinquefolius, Melissa officinalis, Salvia officinalis,
Salvia lavandulaefolia and guaraná.
Andrew has published over 250 peer-reviewed journal articles,
23 book chapters and 2 books. These have have been widely cited (Scopus h-index = 56).
He has attracted over 25 million dollars in research funding,
including as Chief Investigator on national competitive grants from the
UK, Europe and Australia as well as from many industry bodies in
Europe, North America, Asia, New Zealand and Australia.
2006 Andrew took a six-month sabbatical at the Nestlé Research
Centre, Switzerland during the establishment of their Cognitive
Sciences group. He acts as a consultant/expert advisor to many industry
bodies, including various Fortune 500 companies. He works closely with
industry to allow rapid translation of research into evidence-based
products for brain health.
expert advisor to the International Life Sciences Institute Expert
Committee on Nutrition and Mental Performance and an expert witness to
the UK Parliamentary Forum on Food and Health Inquiry on Diet and
Behaviour. He has also acted as an advisor to the Canadian Ministry of
Health. He was a member of the inaugural Australian Research Council
Impact and Engagement panel for Health and medical Sciences.
Andrew has supervised over 20 PhDs and over 100 honours students. He
reviews grants for national and international funding bodies and is on
the editorial board of PLoS ONE, Phytotherapy Research and Nutrients.
He is committed to the public dissemination of science with numerous
appearances in the print, audiovisual and digital media.